|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/4439 | |
| A61K 31/00 | |||
| A61K 31/42 | |||
| A61P 9/10 | |||
| C07D 263/32 | |||
| C07D 401/14 | |||
| C07D 413/12 | |||
| C07D 413/14 | |||
| C07D 417/12 | |||
| C07D 417/14 |
| (11) | Number of the document | 1382336 |
| (13) | Kind of document | T |
| (96) | European patent application number | 02720584.8 |
| Date of filing the European patent application | 2002-04-24 | |
| (97) | Date of publication of the European application | 2004-01-21 |
| (45) | Date of publication and mention of the grant of the patent | 2010-09-08 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/JP2002/004072 |
| Date | 2002-04-24 |
| (87) | Number | WO 2002/087580 |
| Date | 2002-11-07 |
| (30) | Number | Date | Country code |
| 2001128222 | 2001-04-25 | JP |
| (72) |
SUGIYAMA, Yasuo, JP
FUSE, Hiromitsu, JP
HIRAKATA, Masao, JP
TOZAWA, Ryuichi, JP
|
| (73) |
Takeda Pharmaceutical Company Limited,
1-1, Doshomachi 4-chome, Chuo-ku, Osaka,
JP
|
| (54) | USE OF THE ABC EXPRESSION PROMOTOR PIOGLITAZONE FOR THE TREATMENT OF ARTERIOSCLEROSIS OBLITERANS |
| USE OF THE ABC EXPRESSION PROMOTOR PIOGLITAZONE FOR THE TREATMENT OF ARTERIOSCLEROSIS OBLITERANS |